enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Roche joins race for obesity drugs with $2.7 billion Carmot deal

    www.aol.com/news/roche-enters-obesity-drug...

    Roche shares opened up 1.75%, hitting a six-week high on optimism that the weight-loss market will accommodate many rivals. ... Carmot's employees will join Roche's pharmaceuticals division when ...

  3. Roche shares knocked by concern over side effects in obesity ...

    www.aol.com/news/roche-shares-drop-side-effects...

    Side effects data that Roche released on Monday on another early Carmot project, injection CT-388, had also weighed on its shares, for a 5.4% decline so far this week.

  4. Roche - Wikipedia

    en.wikipedia.org/wiki/Roche

    Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue [6] and the leading provider of cancer treatments globally. [7] [8] In 2023, the company’s seat in Forbes Global 2000 was 76. [9]

  5. Roche to fast-track weight loss drugs to compete with rivals ...

    www.aol.com/news/roche-fast-track-weight-loss...

    Roche is among a growing number of would-be rivals to Novo and Eli Lilly, whose weight-loss injections have been in feverish demand, with experts boosting their sales forecasts for such treatments ...

  6. images.huffingtonpost.com

    images.huffingtonpost.com/2012-08-30-3258_001.pdf

    Created Date: 8/30/2012 4:52:52 PM

  7. 800 Westchester Avenue - Wikipedia

    en.wikipedia.org/wiki/800_Westchester_Avenue

    Kevin Roche John Dinkeloo and Associates, LLC [7] [8] The 800 Westchester Avenue complex is a postmodern Class A office building located in Rye Brook, New York . [ 1 ] [ 2 ] It was designed by the architectural firm of Kevin Roche John Dinkeloo and Associates, LLC to serve as the corporate headquarters for General Foods .

  8. Labcorp - Wikipedia

    en.wikipedia.org/wiki/Labcorp

    The acquisition price was reduced to $204 million after federal officials issued subpoenas in an investigation of Medicare billing practices. [ 11 ] [ 12 ] [ 13 ] In April 1995, Hoffmann-La Roche , a division of Roche , contributed Roche Biomedical Laboratories, Inc. and US$186.7 million in cash to National Health Laboratories Holdings, in ...

  9. Roche open to big acquisitions 'if it makes scientific and ...

    www.aol.com/news/roche-open-big-acquisitions...

    Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $20.7 billion deal last year to buy back its ...